Business

Universal Ibogaine Announces Offering of Common Shares

(TheNewswire) Calgary, AB – TheNewswire - May 19, 2023 – Universal Ib...

articleUniversal Ibogaine IncMay 19, 20235/company/universal-ibogaine-inc/news/universal-ibogaine-announces-offering-of-common-shares
Universal Ibogaine Announces Offering of Common Shares

About this update from Universal Ibogaine Inc

[{"type":"text","content":"Universal Ibogaine Announces Offering of Common Shares \n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Calgary, AB –\n \n \n TheNewswire -\n \n \n May 19, 2023 – Universal Ibogaine Inc.\n(\n \n \n TSXV:IBO\n \n \n ) (“\n \n \n UI\n \n \n ” or the “\n \n \n Company\n \n \n ”), a life sciences company with a\nmission to deliver medicalized ibogaine-centered addiction care,\nadvises that it is undertaking an offering of up to 66,666,667 share\n“\n \n \n Units\n \n \n ” at a price of $0.03 per Unit (the “\n \n \n Offering\n \n \n ”) for\nproceeds of up to $2,000,000.  Each Unit will consist of one common\nshare and\n \n \n a one-half common share purchase\nwarrant (a “\n \n \n Warrant\n \n \n ”), with each whole Warrant allowing\nthe holder to acquire an additional UI common share at a fixed price\nof $0.06 per share for a period of one year from closing of the\nOffering.\n \n \n \n \n The proceeds from the Offering are intended to be used\nin completing the Company’s planned ibogaine based clinical trial\napplication with Health Canada, including finalizing a supply\nagreement for ibogaine to be used in the eventual trials, and for\ngeneral working capital purposes.\n \n \n \n \n Closing of the Offering, and the payment of any finders\nfees related thereto, is subject to the required approvals of the TSX\nVenture Exchange\n \n \n \n \n \n About Universal\nIbogaine Inc.\n \n \n \n \n \n \n UI is a life sciences company,\n \n \n \n \n with a mission to\ntransform addiction treatment using medicalized ibogaine through a\nplanned Canadian clinical trial focused on opioid use disorder, and\nultimately to utilize that protocol globally through planned future\nlicensing agreements.\n \n \n \n \n UI\nis concurrently developing a state of the art holistic addiction\ntreatment protocol at its Kelburn Recovery Centre that, which when\npaired with the planned ibogaine detox protocol, is intended to\nrevolutionize the way we treat addiction and drastically improve the\nlives of individuals and families affected by\naddiction.\n \n \n \n \n \n \n NEITHER THE TSX\nVENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS\nDEFINED IN THE POLI...

More updates from Universal Ibogaine Inc